The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.50
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 1.00 (5.714%)
Open: 18.00
High: 18.00
Low: 18.00
Prev. Close: 18.00
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Profit rise for GlobalData, Greencoat keeps dividend

Mon, 28th Feb 2022 19:41

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

OptiBiotix Health PLC - York, England-based life sciences company - For 2021, total invoiced sales rise 47% to GBP2.2 million from GBP1.5 million the year before, while gross profit increases 37% year-on-year to GBP1.2 million from GBP879,000, on reduced intellectual property and R&D costs.

----------

Toople PLC - Letchworth Garden City, England-based telecom services - For the year ended September 30, pretax loss narrows to GBP1.3 million from GBP2.7 million the year before, due to lower administrative costs and an exceptional loss of GBP1.1 million the prior year, related to impairments. Revenue however declines 12% year-on-year to GBP3.0 million from GBP3.4 million, due to the pandemic's effect on Toople's traditional company base. Looking ahead, compared to the final quarter of the 2020 financial year, Toople's first quarter is expected to see a 17% rise in gross profit and 9% increase in sales as the UK returns to more normal conditions.

----------

Ruffer Investment Co Ltd - closed-ended investment company incorporated in Guernsey - As at December 31, net asset value per share increases 2.3% to 287.74 pence from 281.32p at the end of June. NAV total return for the six-month period is 2.8%, driven by a boost in the return of index-linked bonds. Declares dividend per share at 1.55p, up 63% from 0.95p.

----------

Beowulf Mining PLC - developing Kallak iron ore mine in Sweden and Aitolampi graphite mine in Finland - For 2021, pretax loss widens to GBP1.5 million from GBP1.3 million due to a rise in administrative costs. The year features Beowulf awaiting a decision of gaining approval for the Kallak iron ore project in Sweden, and the start of a scoping study for the Aitolampi graphite project in Finland.

----------

Forward Partners Group PLC - London-based investment firm - Expects growth in the value of its Ventures Portfolio for 2021 to meet expectations, with GBP8.8 million invested over the year. As at December 31, cash position stands at GBP32.1 million, and looking ahead, momentum in Ventures portfolio is expected to continue into 2022.

----------

Macau Property Opportunities Fund - Hong Kong-focused property investment company - As at December 31, net asst value per share drops to USD1.51 from USD1.62 the same date a year before, as the company's portfolio value lowers 1.7% over the six-month period to USD259.4 million from USD265.4 million at the end of June.

----------

Quartix Technologies PLC - Newtown, Wales-based vehicle tracking system provider - For 2021, pretax profit drops 6.6% to GBP5.3 million from GBP5.7 million the year before, on revenue which declines 1.2% year-on-year to GBP25.5 million from GBP25.8 million, due to a 53% decline in insurance revenue, after the group chose to end the supply of new installations for its main Insurance client, a decision fuelled by the supply shortage in component parts, raising equipment costs. This more than offset continued growth in Quartix's Fleet division. Declares final dividend of 7.00 pence per share, bringing total payout to 8.50p, down 60% from 21.07p the prior year. Looking ahead, reports strong start to 2022, and targets at least GBP30 million in annualised recurring revenue by end of 2023.

----------

OnTheMarket PLC - Aldershot, England-based operator of online property search portal OnTheMarket.com - For the year ended January 2022, expects to report adjusted operating profit of GBP2.6 million, up 8.3% from GBP2.4 million the year before, on revenue which is set to grow 34% year-on-year to GBP30.8 million from GBP23.0 million.

----------

Greencoat Renewables PLC - Dublin-based investor in euro-denominated renewable energy infrastructure assets - As at December 31, net asset value per share increases 8.3% year-on-year to 105.1 euro cents from 101.0 cents, as the company's portfolio generates 1,522 gigawatt-hours of electricity for 2021, a 8.4% increase from 1,404GWh in 2020 and 16% below budget. Declares dividend per share at 6.06 cents for the year, in line with 2020. Targets 6.16 cents dividend for 2022. Portfolio comprises 25 assets with net generating capacity of 800 megawatts.

----------

Kosmos Energy Ltd - oil and gas exploration and production along Atlantic Margins - For the fourth quarter of 2021, swings to pretax profit of USD155.8 million from USD16.3 million loss, as revenue rises 56% year-on-year to USD572.6 million from USD366.3 million. Net production in the quarter averages 70,000 barrels of oil equivalent per day, up from 60,200 barrels a year prior. For 2021, pretax loss narrows sharply to USD43.4 million from USD416.8 million the year before, on revenue which grows 48% to USD1.33 billion from USD896.2 million. Looking ahead, Kosmos expects production for 2022 to be between 67,000 to 71,000 barrels of oil per day.

----------

Oncimmune Holdings PLC - Nottingham-based immunodiagnostics developer - For the six months ended November 2021, pretax loss widens to GBP4.9 million from GBP2.8 million a year before, due to a rise in administrative costs and a 22% decline in revenue to GBP1.4 million from GBP1.8 million, on lower than expects contract signings in the ImmunoINSIGHTS business. Looking ahead, contract signing have accelerated from the second quarter onwards, and annual revenue from ImmunoINSIGHTS is set to be at least GBP6.0 million. Oncimmune will also move its year-end date to August 31 from May 31. Company has also signed a contract with Alphabet Inc firm Verily Life Sciences LLC, for the autoantibody profiling of patients who have been infected with Covid-19 and has developed long-lasting symptoms. Should the discovery phase be successful, both firms will move to file patent applications for developing a companion diagnostic.

----------

GlobalData PLC - London-based data analytics and consulting company - For 2021, pretax profit rises 14% to GBP32.8 million from GBP28.6 million the year before, on revenue which grows 6% year-on-year to GBP189.3 million from GBP178.4 million, on strong renewal rates and an 8% rise in subscriptions. Declares final dividend of 13.2 pence per share, bringing the total payout to 19.3p, up 14% vs 17.0p. Looking ahead, GlobalData says it is well positioned to make further progress in 2022, due to its strong invoiced forward revenue position of GBP107.7 million.

----------

Made Tech Group PLC - London-based provider of technology services to government and healthcare organisations - For the six months ended November 30, pretax profit hikes to GBP121,000 from GBP12,000 a year prior, on revenue which more than doubles year-on-year to GBP11.7 million from GBP5.1 million through an expanded client base, and the awarding of the company's largest contract to date. Sales bookings for the period total GBP26.5 million, compared to GBP10.7 million. Looking ahead, expects challenges related to IR35 and staffing of public sector contracts to affect trading performance in the fourth quarter of the current financial year and first quarter of the next. In addition, company announces it is part of consortium which has been awarded pact with NHS Digital in UK worth up to GBP37.5 million. "The contract has been awarded through the NHS Digital Capability framework and will be delivered jointly by Made Tech and its consortium partner Answer Digital, with Made Tech expected to receive approximately half of the total contract value. Delivery under the contract has already commenced," Made Tech adds.

----------

Safestyle UK PLC - Bradford, England-based PVCu double-glazed windows provider - Following cyberattack in late January, has largely recovered, and expects the level of disruption to reduce over the next month or so. However, the interruption to Safestyle's order processing is expected to have a 10% impact on revenue for the company's first half, and a material effect on earnings. However, the company has maintained its guidance for the second half, and has chosen to not change its investment plans for 2022. The cyber attack also delays Safestyle's annual results release to April 21.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
19 Jan 2021 16:30

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

EXECUTIVE CHANGE SUMMARY: Next CEO Wolfson Joins Board Of Deliveroo

Read more
11 Jan 2021 17:29

IN BRIEF: OptiBiotix Inks Agreement For Microbiome Products Research

IN BRIEF: OptiBiotix Inks Agreement For Microbiome Products Research

Read more
5 Jan 2021 17:55

UK EXECUTIVE CHANGE SUMMARY: Saga Insurance CEO Resigns After One Year

UK EXECUTIVE CHANGE SUMMARY: Saga Insurance CEO Resigns After One Year

Read more
9 Dec 2020 16:08

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

UK EXECUTIVE CHANGE SUMMARY: Wizz Poaches From easyJet; New Cenkos CEO

Read more
18 Nov 2020 14:53

IN BRIEF: OptiBiotix Grants License for Cardiovascular Health Product

IN BRIEF: OptiBiotix Grants License for Cardiovascular Health Product

Read more
18 Nov 2020 12:23

OptiBiotix grants LPLDL licence to Canada's Genuine Health

(Sharecast News) - Life sciences company OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary ProBiotix Health has granted a non-exclusive licence for 'LPLDL' to Genuine Health, for a cardiovascular health product in Canada and the United States.

Read more
12 Oct 2020 14:34

IN BRIEF: OptiBiotix Notes Australia And New Zealand Product Launch

IN BRIEF: OptiBiotix Notes Australia And New Zealand Product Launch

Read more
12 Oct 2020 14:00

OptiBiotix products launch into retail in Australia, New Zealand

(Sharecast News) - Life sciences company OptiBiotix Health announced the launch of meal replacement shakes and bars containing its 'OptiBiome' proprietary weight management technology under the 'Optislim' brand with the Woolworths and Chemist Warehouse retailers, and online, in Australia and New Zealand.

Read more
8 Oct 2020 21:16

UK EXECUTIVE CHANGE SUMMARY: Silence Wants US CFO After Nasdaq Float

UK EXECUTIVE CHANGE SUMMARY: Silence Wants US CFO After Nasdaq Float

Read more
6 Oct 2020 14:36

IN BRIEF: OptiBiotix's ProBiotix Inks Singaporean Deal For CholBiomeX3

IN BRIEF: OptiBiotix's ProBiotix Inks Singaporean Deal For CholBiomeX3

Read more
2 Oct 2020 11:13

OptiBiotix Notes FDA Approval For Investigation Into Partner's New Drug

OptiBiotix Notes FDA Approval For Investigation Into Partner's New Drug

Read more
2 Oct 2020 10:17

OptiBiotix shares rise as partner Seed gets FDA approval

(Sharecast News) - Life sciences company OptiBiotix Health announced on Friday that one of its partners, Seed Health, has received US Food and Drug Administration authorisation for an investigational new drug (IND) application for 'DS-01'.

Read more
24 Sep 2020 12:25

OptiBiotix revenue improves fivefold in first half

(Sharecast News) - Life sciences company OptiBiotix Health reported first-half revenue growth to £0.74m in its first half on Thursday, which was a five times increase in revenues from the first half of 2019.

Read more
24 Sep 2020 12:04

IN BRIEF: OptiBiotix Pretax Loss Narrows, Prepares For Dual Listing

IN BRIEF: OptiBiotix Pretax Loss Narrows, Prepares For Dual Listing

Read more
22 Sep 2020 15:04

IN BRIEF: OptiBiotix Inks SlimBiome License Deal With HiLife Vitamins

IN BRIEF: OptiBiotix Inks SlimBiome License Deal With HiLife Vitamins

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.